Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Moingeon

Showing results (1-10 of 111) with videos related to

Pageof 12
Sort By:
Arbeiten Aus Dem Paul-Ehrlich-Institut (Bundesamt Fur Sera Und Impfstoffe) Zu Frankfurt A.M|March 31, 2007
Clinical trials with allergen products: in search of biological markers of efficacyPhilippe Moingeon
Human Vaccines & Immunotherapeutics|October 26, 2012
Adjuvants for allergy vaccinesPhilippe Moingeon
Expert Review of Vaccines|September 5, 2014
Progress in the development of specific immunotherapies for house dust mite allergiesPhilippe Moingeon
Immunology and Allergy Clinics of North America|December 1, 2015
Biomarkers for Allergen Immunotherapy: A "Panoromic" ViewPhilippe Moingeon
Expert Review of Clinical Immunology|June 27, 2024
Harnessing the power of AI-based models to accelerate drug discovery against immune diseasesPhilippe Moingeon
International Archives of Allergy and Immunology|December 15, 2015
Will Allergen Fusion Bring New Energy to Immunotherapy?Philippe Moingeon
Trends in Pharmacological Sciences|June 2, 2023
Artificial intelligence-driven drug development against autoimmune diseasesPhilippe Moingeon
Medecine Sciences : M/S|May 31, 2024
[Artificial intelligence-driven drug development against autoimmune diseases]Philippe Moingeon
The Journal of Allergy and Clinical Immunology. in Practice|February 26, 2014
Update on immune mechanisms associated with sublingual immunotherapy: practical implications for the clinicianPhilippe Moingeon
Immunotherapy|February 21, 2012
Novel routes for allergen immunotherapy: safety, efficacy and mode of actionPhilippe Moingeon, Laurent Mascarell
Pageof 12

Showing results (1-10 of 111) with videos related to

Sort By:
Pageof 12
Arbeiten Aus Dem Paul-Ehrlich-Institut (Bundesamt Fur Sera Und Impfstoffe) Zu Frankfurt A.M|March 31, 2007
Clinical trials with allergen products: in search of biological markers of efficacyPhilippe Moingeon
Human Vaccines & Immunotherapeutics|October 26, 2012
Adjuvants for allergy vaccinesPhilippe Moingeon
Expert Review of Vaccines|September 5, 2014
Progress in the development of specific immunotherapies for house dust mite allergiesPhilippe Moingeon
Immunology and Allergy Clinics of North America|December 1, 2015
Biomarkers for Allergen Immunotherapy: A "Panoromic" ViewPhilippe Moingeon
Expert Review of Clinical Immunology|June 27, 2024
Harnessing the power of AI-based models to accelerate drug discovery against immune diseasesPhilippe Moingeon
International Archives of Allergy and Immunology|December 15, 2015
Will Allergen Fusion Bring New Energy to Immunotherapy?Philippe Moingeon
Trends in Pharmacological Sciences|June 2, 2023
Artificial intelligence-driven drug development against autoimmune diseasesPhilippe Moingeon
Medecine Sciences : M/S|May 31, 2024
[Artificial intelligence-driven drug development against autoimmune diseases]Philippe Moingeon
The Journal of Allergy and Clinical Immunology. in Practice|February 26, 2014
Update on immune mechanisms associated with sublingual immunotherapy: practical implications for the clinicianPhilippe Moingeon
Immunotherapy|February 21, 2012
Novel routes for allergen immunotherapy: safety, efficacy and mode of actionPhilippe Moingeon, Laurent Mascarell
Pageof 12